2022 Interactive Breakout Discussions

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.



4:35 PM Find Your Table and Meet Your Moderators

4:40 PM Interactive Discussions

5:25 PM Welcome Reception in the Exhibit Hall

6:40 PM Close of Day

Interactive Breakout Discussion Group Topics for SCOPE 2022 (co-moderators and discussion points coming soon):

1. Reducing CO2 Footprint and Waste for Sustainable Clinical Trials: Challenges and Opportunities 

2. Integrating Early Patient and Site Insights in Protocol Development and Site Selection

3. Implementing a Data-Driven Site Selection Capability with RWD, Modelling and Analytics

4. Building Diversity, Equity and Inclusion (DE&I) into Trial Design and Ops

5. Strategies for Patient-Centric Trial Design and Digital Patient Engagement

6. Future State of Trials Due To COVID-19: Planning for and Enabling Smooth Start Up in Multi-Center, Hybrid and Decentralized Trials

7. Engaging and Understanding Patient Behavior and Behavioral Economics to Improve Accessibility, Retention and Outcomes

8. Budgeting for and Contracting with New Technology Companies: Strategies and Challenges

9. Re-Examining Outsourcing Models in the COVID Era and Beyond: FSP vs. Hybrid vs. Strategic Partnerships

10. Managing Resources and Proper Oversight for Outsourced Decentralized Clinical Trials

11. Developing Tools for Speeding Study Start-Up: Contracting, Budgeting, Capacity Planning

12. RWD To Accelerate Design and Execution of Clinical Trials

13. Data Management for the “New Normal”

14. Validating Digital Biomarkers and Endpoints

15. Decentralized and Hybrid Trials: The New Ecosystem

16. #NOGOINGBACK: Thriving for Sustainable Innovation

17. The Car is Ready, But No Fuel in the Tank: Overcoming Data Challenges of RBQM

18. Integrating Biomarkers in Global Trials

19. Medical Device Clinical Trial Design and Operations

20. Adopting Supply Chain Predictive Analytics to Shift from Reactive to Proactive Decision-Making

Download Brochure